GENMAB AS DK 1 financial statements, including revenue, expenses, profit, and loss

The total revenue of GE9 for the last quarter is 554.06 M EUR, and it's 11.68% lower compared to the previous quarter. The net income of Q1 24 is 177.20 M EUR.